Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hello ladies, happy valentine to both of you!
And to NNVC !
If Nanoviricides has really found a way to cure dengue fever,
I think it is the interest of Dr. Harris to represent them.
After all, Eva is a scientist who wants to overcome this disease.
You guys are ready? Another 4 days and Kaboom Kaboom Kaboom !!!!
GOOOOOOOOOOOOOOOOOOOOOOO NNVC!!!!!!!!!!!!!!
Agree!
And that is why the time is right to invest at this price.
Forza NNVC !
ha ha ha! You are good, you do not need french lesson !
Oui un bon camembert, et un fromage de chevre feront l'affaire.
Merci! Grazie! Thank you!
And Salute a tutti e 2!
Yes it's true, you're right, we have a Rendez vous.
I will keep the 2nd bottle for Nanopat!
At $20.00 you will be the first with whom I will drink.
That's what I meant. If not we have a big problem.
Yes and a lot of Prosseco !
To me, we'll have good news.
I am sitting very comfortably on my chairs.
Foooooooooooooorza NNVC !!!!!!
More History:
WEST HAVEN, Conn., Jun 21, 2010 -- NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company") reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley (UC Berkeley).
Treatment with one of the anti-Dengue nanoviricides(R) led to survival of 50% of the animals for the duration of study in the ADE model. In addition, animals treated with several anti-Dengue nanoviricides survived longer than the control animals treated with vehicle alone. This ADE model of infection is uniformly fatal in 100% of the infected animals within 5 days after infection.
Dr. Harris is a leading researcher in the field of dengue viruses. Her group has developed a unique animal model for the most severe and potentially fatal form of Dengue virus infection in humans, Dengue Hemorrhagic Fever/Dengue Shock Syndrome (DHF/DSS). The model emulates the "Antibody-Dependent Enhancement (ADE)" of Dengue virus infection in humans that is believed to lead to DHF/DSS.
"We are very excited about these results," said Professor Harris, adding, "This is a very important demonstration of a viable drug candidate leading to significant survival in the ADE model of Dengue virus infection. I believe nanoviricides show great promise in our model and against severe dengue disease."
"The first screen has already shown that we are on the right path," said Anil R. Diwan, PhD, President of the Company, adding, "We believe we have at least one potential drug candidate against Dengue now."
"We have been able to produce an effective drug candidate against dengue in a very short time," said Eugene Seymour, MD, MPH, Chief Executive Officer of the Company, adding, "This demonstrates the strength of the nanoviricides technology platform."
The Company has previously reported significant efficacy of several nanoviricides in two different in vitro (cell culture) tests against dengue virus type 2 conducted by Professor Harris' Lab. Some of these nanoviricides were tested in vivo in the present study.
This gives me complete confidence.
Let's not forget the agreement signed by Dr.Eva Harris and NanoViricides on February 17, 2010.
I do not see why Eva would not support NNVC after this agreement.
NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley 17. February 2010 00:59
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reports that it has signed a research and development agreement with Dr. Eva Harris’s laboratory at the University of California, Berkeley (UC Berkeley).
“We will now be able to rapidly advance our anti-dengue therapeutics program.”
Under this agreement, Dr. Harris and coworkers will evaluate the effectiveness of nanoviricides® drug candidates against various dengue viruses. Cell culture models as well as in vivo animal studies will be employed for testing the drug candidates.
The Company believes that a nanoviricide drug under development can be expected to be a broad-spectrum anti-dengue antiviral treatment capable of attacking all four dengue virus serotypes and their variant strains. Currently there are no approved vaccines for the prevention of dengue, nor drugs for treatment of dengue virus infection. The worldwide market size for an effective anti-dengue treatment may be as large as that for Hepatitis C virus treatment, or in the billions of dollars, based on current population exposure data.
If so, we no longer talk about $2.00 per share.
But $10.00, then $20.00, then .....
Maybe you can get a discount ?
I believe you.
This sounds like the calm before the storm.
That's 4 days NNVC is at $ 1.26 - $ 1.28.
I will not be surprised to see a reaction from Today or Tomorrow.
It's interesting to see the different personalities on that board!
I am having fun!
Dr. Feelgood, since I read you, your predictions are always been fair, and I find your explanations very understandable and logical.
I believe you when you say that NNVC will be at $2.00 in 15 days or 3 weeks, it will happen.
Thank you for continuing to give us your opinion.
I would like to be there.
Thank you Patricia.
Good morning Aznavour.
"Oggi abbiamo bisogno di salsa piccante"
We need hot sauce for NNVC, : Salsa a l'arrabbiata !!!!!!!
FORZA NNVC !!!!
I agree.
Love the way you are thinking!
And the 4 ?
Grazie a Dio !!
Here we go !!!!!!
Fantastic !
Hopefully NNVC will pass the $2 mark !!!
HA HA HA ! Ho well ! I think I need to take English courses.
So, shortening does not work for you, you should reconsider your method.
And, have you had much success with NNVC?
Yes. I think NNVC will increase from today.
Everyone knows that February 15 is an important date.
For now it is a good opportunity to buy.
Hawaii should be the first step to a great trip around the world!
FOOOOOOOORZAAAAAAAAAAA NNVC !!
It was great, we had a good snow.
We were in Park city.
Yes I miss my country and my family a lot, but I am a happy man.
I hope to meet you after our NNVC success!
We are talking from 2 to 4 years.
Good luck and Forza NNVC.
By the way, your Italian is good.
We must be patient, as we know we all expect good news on Feb.15.
As we have seen repeatedly, the stock reacted very strongly to any good news.
The stock going up and down is normal, this is part of the game.
It was! Now 1.56.